Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Oct 22, 4:30 AMMiddle East government contract PR lifts BIO-key 50% in pre-market
Index
-
Market Cap
6.29M
Enterprise Value
5.77M
Income
-3.47M
Sales
6.86M
Book/sh
3.99
Cash/sh
0.68
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
42
IPO
Feb 21, 1997
P/E
-
Forward P/E
14.05
PEG
-
P/S
0.92
P/B
0.78
P/C
4.56
P/FCF
-
EV/EBITDA
-
EV/Sales
0.84
Quick Ratio
1.14
Current Ratio
1.26
Debt/Eq
0.20
LT Debt/Eq
0.02
Option/Short
No / Yes
EPS (ttm)
-4.07
EPS next Y
0.22
EPS next Q
-0.35
EPS this Y
76.52%
EPS next Y
113.58%
EPS next 5Y
-
EPS past 3/5Y
65.61% 50.83%
Sales past 3/5Y
-5.43% 15.92%
EPS Y/Y TTM
67.82%
Sales Y/Y TTM
-0.79%
EPS Q/Q
72.26%
Sales Q/Q
13.15%
Insider Own
6.11%
Insider Trans
0.00%
Inst Own
0.08%
Inst Trans
-4.78%
ROA
-38.54%
ROE
-62.01%
ROIC
-78.50%
Gross Margin
81.75%
Oper. Margin
-47.00%
Profit Margin
-50.58%
SMA20
33.19%
SMA50
19.14%
SMA200
-33.36%
Trades
Shs Outstand
2.04M
Shs Float
1.91M
52W High
19.70 -84.31%
52W Low
1.55 99.35%
Volatility
19.88% 24.09%
ATR (14)
0.61
RSI (14)
59.06
Beta
0.53
Rel Volume
16.86
Avg Volume
4.60M
Volume
3,876,062
Perf Week
17.49%
Perf Month
51.47%
Perf Quarter
-34.95%
Perf Half Y
-49.24%
Perf YTD
-42.68%
Perf Year
-59.24%
Perf 3Y
-91.86%
Perf 5Y
-99.44%
Perf 10Y
-99.93%
Prev Close
2.74
Price
3.09
Change %
12.77%
Oct-22-26 03:59AM
Oct-13-26 09:53AM
08:29AM
04:01AM
Sep-29-26 10:52AM
03:30AM Loading…
03:30AM
Sep-23-26 07:59AM
Sep-01-26 07:59AM
Aug-14-26 07:00PM
Aug-13-26 05:00PM
Aug-11-26 08:30AM
Aug-10-26 03:59AM
Aug-07-26 07:59AM
Aug-06-26 06:59AM
Jul-28-26 02:59AM
BIO-key International, Inc. engages in the provision of an identity and access management platform. The firm's products include PortalGuard, Admin Panel, Hardware, Identity-Bound Biometrics, and MobileAuth. It offers its services to the education, finance, government, healthcare, manufacturing, and retail industries. The company was founded on January 7, 1993 and is headquartered in Holmdel, NJ.
Chairman & CEOMr. Michael W. DePasquale
MD of Hong Kong & Vice-Chairman of the BoardMr. Kwok Fong Wong
Chief Financial OfficerMs. Cecilia C. Welch
Senior VP of Strategy & Compliance and Chief Legal OfficerMr. James David Sullivan
Chief Technology OfficerMs. Mira K. LaCous